(Q35166739)

6 August 2017

1 reference

title

Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality (English)

1 reference

6 August 2017

1 reference

Boni Elewski

1

1 reference

6 August 2017

Amir Tavakkol

series ordinal

2

1 reference

6 August 2017

publication date

1 December 2005

1 reference

Therapeutics and Clinical Risk Management

6 August 2017

published in

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

299-306

1 reference

The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Drug interactions: Proteins, pumps, and P-450s

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

The safety and efficacy of terbinafine in patients with diabetes and patients who are HIV positive

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Pharmacokinetics of antifungal agents in onychomycoses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Persistent impairment of taste associated with terbinafine

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Drug interactions of the newer oral antifungal agents

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Onychomycosis: therapeutic update

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Safety of oral terbinafine for toenail onychomycosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasis.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Taste disorders and terbinafine

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Kinetics and spectrum of activity of oral antifungals: the therapeutic implications

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Terbinafine in onychomycosis of the toenail: A novel treatment protocol

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Short term treatment of dermatophyte onychomycosis with terbinafine

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Effect of onychomycosis on quality of life.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjects.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

The prevalence of onychomycosis in Finland.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

Terbinafine-associated hepatic injury

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661633

[Terbinafine-induced cholestatic liver injury]

27 September 2018

1 reference

12 December 2020

Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day

1 reference

12 December 2020

Peripheral edema due to nifedipine-itraconazole interaction: a case report

1 reference

12 December 2020

[Hepatitis attributed to the use of terbinafine]

1 reference

12 December 2020

Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine

1 reference

12 December 2020

Oral terbinafine and erythema multiforme

1 reference

12 December 2020

Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group

1 reference

12 December 2020

Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study

1 reference

12 December 2020

Acute generalized exanthematous pustulosis associated with oral terbinafine

1 reference

12 December 2020

Acute generalized exanthematous pustulosis induced by itraconazole

1 reference

12 December 2020

The implications and management of drug interactions with itraconazole, fluconazole and terbinafine

1 reference

12 December 2020

[Acute hepatitis associated with terbinafine]

1 reference

12 December 2020

Hepatitis associated with terbinafine therapy: three case reports and a review of the literature

1 reference

12 December 2020

Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine

1 reference

12 December 2020

Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial

1 reference

12 December 2020

Pharmacokinetics and pharmacology of terbinafine and itraconazole

1 reference

12 December 2020

Terbinafine: tolerability in general medical practice

1 reference

12 December 2020

Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine

1 reference

12 December 2020

Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group

1 reference

12 December 2020

Comparative bioavailability of a microsize and ultramicrosize griseofulvin formulation in man

1 reference

12 December 2020

Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions

1 reference

12 December 2020

A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis

1 reference

12 December 2020

Identifiers

PMC publication ID

1661633

1 reference

6 August 2017

1 reference